Regular Article
Accumulation of 5-Aminolevulinic Acid-Induced Protoporphyrin IX in Normal and Neoplastic Human Endometrial Epithelial Cells

https://doi.org/10.1006/bbrc.1996.1106Get rights and content

Abstract

The aim of this study was to evaluate 5-Aminolevulinic acid (ALA)-induced fluorescence of normal and neoplastic endometrial epithelial cells for diagnosis and photodynamic treatment. Fluorescence of ALA-induced PpIX in vitro was measured by flow cytometry in two different human endometrial adenocarcinoma cell lines and in normal cells cultivated from fresh endometrial tissue of three premenopausal patients. The cells were analysed after incubation with different concentrations of ALA during 3, 6, or 24 hours. Both tumor cell lines showed a statistically significant higher fluorescence of PpIX than normal epithelial cells after incubation with 1 mg ALA per ml medium during 24 hours. The well-differentiated cancer cells produced significantly more PpIX than the poorly differentiated cancer cells. Relative PpIX intensity of the two cancer cell lines correlated with cell proliferation rate as measured by the doubling times of the cells. Higher accumulation of Pp IX in neoplastic endometrium compared to normal endometrial epithelial cells may provide targeted biopsies and selective photodynamic destruction of neoplastic micro-lesions.

References (0)

Cited by (25)

  • Advances in 5-aminoketovaleric acid(5-ALA) nanoparticle delivery system based on cancer photodynamic therapy

    2022, Journal of Drug Delivery Science and Technology
    Citation Excerpt :

    reported the first clinical study on the application of exogenous 5-ALA in the treatment of skin cancer [12]. In the following decade, researchers have successively applied 5-ALA in photodynamic therapy for bladder cancer [13], endometrial cancer [14], lung cancer [15], glioma [16], colon cancer [17] oral cancer [18], and other cancers (Table 1). However, as research progressed, researchers found that low permeability and poor targeting of 5-ALA affected its clinical anti-tumour effects [19,20].

  • Clinical application of photodynamic diagnosis and photodynamic therapy for gynecologic malignant diseases: A review

    2018, Photodiagnosis and Photodynamic Therapy
    Citation Excerpt :

    After injection of 5ALA into the human endometrium, 5ALA-derived PpIX accumulated in the endometrium more than in the myometrium [49,50], the amount of PpIX in endometrial glands was highest 4 to 8 h after intrauterine injection of 5ALA [50], endometrial glands were more fluorescence-positive in premenopausal than in postmenopausal patients [50], and fluorescent-positive rates of PpIX were higher in patients histopathologically diagnosed with endometrial hyperplasia and secretory phase endometrium [51]. In a cellular study, Wyss-Desserich administered 5ALA to well-differentiated HEC-1 A endometrial cancer cells, poorly differentiated KLE cells, and normal endometrial cells, and found that the cancer cells had more PpIX than normal cells [52]. Data from these basic experiments make it possible to conduct a uterine cavity-targeted biopsy using PDD and develop a less-invasive fertility preservation treatment.

  • Risk factors for developing oral 5-aminolevulenic acid-induced side effects in patients undergoing fluorescence guided resection

    2013, Photodiagnosis and Photodynamic Therapy
    Citation Excerpt :

    There is very little or no side effects in most patients at this dose. However hypotension, liver enzyme dysfunctions and mild photosensitivity have been reported in some cases [1–8]. This study evaluated 5-ALA induced side effects in a cohort of 90 patients treated in Ninewells Hospital and Medical School and review the literature.

View all citing articles on Scopus
1

Corresponding author (Switzerland). Fax: 41.1.255 44 33.

View full text